Next Article in Journal
A ‘Furry-Tale’ of Zika Virus Infection: What Have We Learned from Animal Models?
Next Article in Special Issue
Modeling Host-Virus Interactions in Viral Infectious Diseases Using Stem-Cell-Derived Systems and CRISPR/Cas9 Technology
Previous Article in Journal
KDELR2 Competes with Measles Virus Envelope Proteins for Cellular Chaperones Reducing Their Chaperone-Mediated Cell Surface Transport
Previous Article in Special Issue
Engineering RNA Virus Interference via the CRISPR/Cas13 Machinery in Arabidopsis

Viral Delivery Systems for CRISPR

Edward S. Harkness Eye Institute, New York-Presbyterian Hospital, New York, NY 10032, USA
Jonas Children’s Vision Care and Bernard & Shirlee Brown Glaucoma Laboratory, Columbia University, New York, NY 10032, USA
Omics Laboratory, Byers Eye Institute, Department of Ophthalmology, Stanford University, Palo Alto, CA 94301, USA
Veterans Affairs Palo Alto Health Care, Palo Alto, CA 94301, USA
Department of Pathology & Cell Biology, Stem Cell Initiative (CSCI), Institute of Human Nutrition, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
Author to whom correspondence should be addressed.
Viruses 2019, 11(1), 28;
Received: 17 December 2018 / Revised: 31 December 2018 / Accepted: 1 January 2019 / Published: 4 January 2019
(This article belongs to the Special Issue Applications of CRISPR Technology in Virology 2018)
The frontiers of precision medicine have been revolutionized by the development of Clustered Regularly-Interspaced Short Palindromic Repeats (CRISPR)/Cas9 as an editing tool. CRISPR/Cas9 has been used to develop animal models, understand disease mechanisms, and validate treatment targets. In addition, it is regarded as an effective tool for genome surgery when combined with viral delivery vectors. In this article, we will explore the various viral mechanisms for delivering CRISPR/Cas9 into tissues and cells, as well as the benefits and drawbacks of each method. We will also review the history and recent development of CRISPR and viral vectors and discuss their applications as a powerful tool in furthering our exploration of disease mechanisms and therapies. View Full-Text
Keywords: CRISPR; viral vectors; gene therapy; animal models; gene editing CRISPR; viral vectors; gene therapy; animal models; gene editing
MDPI and ACS Style

Xu, C.L.; Ruan, M.Z.C.; Mahajan, V.B.; Tsang, S.H. Viral Delivery Systems for CRISPR. Viruses 2019, 11, 28.

AMA Style

Xu CL, Ruan MZC, Mahajan VB, Tsang SH. Viral Delivery Systems for CRISPR. Viruses. 2019; 11(1):28.

Chicago/Turabian Style

Xu, Christine L.; Ruan, Merry Z.C.; Mahajan, Vinit B.; Tsang, Stephen H. 2019. "Viral Delivery Systems for CRISPR" Viruses 11, no. 1: 28.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop